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Abstract 
The number of cases infected with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), which causes 
COVID-19, has been steadily rising globally. Iran, one of the countries with a relatively high number of positive cases, 
has an inevitable role to play in controlling the pandemic by implementing effective policies and countermeasures to 
interrupt the viral transmission chain. Epidemic restrictions implemented following an Iranian presidential mandate 
were especially effective following the Nowruz holidays—the solar New Year celebration in the Persian-speaking 
culture. These restrictions started flattening the incidence curve of the epidemic in Iran two weeks after implementation, 
from 10 April 2020. Supplying sufficient face masks, disinfectants, sanitizers, and medical equipment to all 
government-run and non-for-profit hospitals were included in the presidential mandate. We believe that continuing this 
policy strictly will be required for further controlling the pandemic throughout the country. 
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Introduction 
December 2019 saw the inception of a viral 
outbreak in Wuhan, China, which attracted much 
international attention (1). The causative agent of 
the outbreak was identified as the severe acute 
respiratory syndrome coronavirus-2 (SARS-CoV-
2), which belongs to the same Coronavirus family 
that caused the other two moderate epidemics -the 
Middle East respiratory syndrome and severe acute 
respiratory syndrome- 20 years ago. The 
corresponding disease caused by SARS-CoV-2, 
COVID-19, thus far has had a wide range of clinical 
presentations from no symptoms to severe 
respiratory distress syndrome (2) with many other 
recently described associations, such as loss of 
smell and taste (3,4); gastrointestinal symptoms 
such as loss of appetite, nausea, and diarrhea (4,5); 
cardiovascular outcomes, strokes, and blood clots 
(6-9,4); frostbite-like rash on toes (4); delirium (4); 
and the multisystem inflammatory syndrome or 
Kawasaki-disease-like presentation in young 
children (10,4). Nevertheless, reportedly an 
estimated 44% of COVID-19 cases may have 
spread from person to person before any symptom 
appeared (11), confirming the case for 
asymptomatic carriers (12-14) and making SARS-
CoV-2 one of the most contagious viruses. 
According to an updated report by the World Health 
Organization (WHO), 67,402,630 cases were 
confirmed globally as of 7 December 2020 (15), 
while humanity grapples with many and 
multifaceted repercussions of the pandemic. 
Therefore, the implementation of important health 
measures has been necessary to interrupt the chain 
of viral transmission to effectively control the 
pandemic (16). In some countries like Iran, the 
implications of the pandemic and its control are 
profound. Daily road or air travel within the country 
or internationally is highly frequent. Iran could have 
easily facilitated the viral spread to its neighboring 
countries. Some Iranian traditions and their social 
fabric inherently clash with social distancing. For 
example, in the southwest Khuzestan province, the 
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number of people attending the funeral ceremonies 
of some COVID-19 victims has reached 400 at a 
time, reportedly in March 2020. Nevertheless, 
controlling the spread of SARS-CoV-2 in Iran 
deserved attention when the incidence curve of the 
pandemic was being gradually controlled. 
Iran’s restrictive measures 
From the emergence of the initial confirmed cases 
of COVID-19 in the Chinese city Wuhan until now, 
many countries have adopted a principally uniform 
or a mixed combination of the counterstrategies 
suggested controlling the spread of the virus within 
their respective borders. However, each public-
health system needs to actively modify the 
countermeasures according to domestic factors, 
including socioeconomic status and agenda, cultural 
or religious sensitivities, or their political arena. 
Iran, with more than 84 million residents  
(See https://www.worldometers.info/world-
population/iran-population/), acted quickly after 
considering the collective expert medical and WHO 
advice.  
Here, we highlight some exemplary measures that 
may have encouragingly facilitated the flattening of 
the incidence curve of the COVID-19 pandemic in 
Iran. First, dissemination of hand sanitizers and face 
masks was initiated, just before the Nowruz 
celebrations, while the national television 
broadcaster began promoting many timely and 
sensible campaigns to encourage the Iranian people 
to begin self-isolating and start working from home. 
Furthermore, an Iranian presidential directive issued 
on 5 April 2020, just after Nowruz, called upon the 
Minister of Health and Medical Education with 
other relevant organizations to adjust the 
countermeasures and mandate a Smart Social-
Distancing Program (SSDP) in all the provinces, 
except Tehran (17). Hence, the ministry was to 
cooperate with the “Iranian National Task Force for 
Fighting Coronavirus” to provide all the relevant 
supplies (face masks, disinfectants, sanitizers, and 
medical equipment) and to implement the newly 
modified countermeasures as soon as practicable 
(17). Accordingly, SSDP mandated closure of all 
the mosques; banning of all the religious gatherings 
and ceremonies (e.g., Ramadan and Eid); closure of 
the football and other sporting stadiums; closure of 
the schools and universities; and closure of the big 
shopping centers until further notice. Additionally, 
SSDP was advertised through waves of media 
releases emphasizing the importance of physical 
distancing in the marketplaces and other public 
places such as recreation parks. (We understand that 
some industries, agriculture, municipalities, and 
essential services- like defense and security, 
medical, and emergency services- cannot be shut 
down.)  
We note that Iran is now under strict economic 
sanctions, which have hampered wider government 
support to vulnerable social classes during the 
quarantine; therefore, adopting SSDP to gradually 
reopen the country’s economy is a rational decision.  
Thus, SSDP was designed to help the authorities 
achieve two ideal goals: 1) flatten the curve; and 2) 
cautiously operate all essential organizations and 
services with mass-gathering needs (18).  
Following SSDP, the number of new COVID-19-
infected cases gradually decreased. For example, 
according to World meter, the daily number of new 
cases peaked at 3,186 on 30 March, whereas 983 
cases per day were recorded on 30 April 2020. 
Similarly, the number of active COVID-19 cases 
waned while the number of recovered cases 
remained steady. However, a new surge of positive 
cases referred to hospitals in the Khuzestan 
province, and the government ordered a new round 
of lockdown restrictions for the entire Khuzestan 
(19, 20). Apparently disobeying the mandate by the 
general population has been the most important 
reason underlying the new surge of the positive 
cases. Thus, coordinated observance of the 
epidemic restrictions in all the provinces could have 
helped SSDP to prevent the new incidence waves of 
the COVID-19 in Iran. 
Conclusion 
SSDP has been relatively promising for the Iranian 
public-health services and will take them beyond 
the present trend of the pandemic, although more 
time is needed to completely flatten the incidence 
curve, especially the emerging surge of the COVID-
19-infected cases. Conclusive implementation of a 
restrictive measure against the COVID-19 
pandemic should consider the national status quo 
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instead of generalizing the suggested global 
countermeasures to all the different nations.  
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